Podcast

Lucia Novak, on Clinical Inertia in Diabetes: How Did We Get Here?

01/23/2019

 

In part 1 of this series, board-certified nurse practitioner Lucia Novak, director of Riverside Diabetes Center, defines clinical inertia and outlines patient- and practitioner-level factors that may impede appropriate management of your patients’ diabetes.

 

 

Lucia Novak, MSN, ANP-BC, BC-ADM, CDTC, is a board-certified nurse practitioner, director of the Riverside Diabetes Center, and adjunct assistant professor in the Graduate School of Nursing at Uniformed Services University of the Health Sciences in Maryland.

 

Additional Reading:

 

Edelman SV, Polonsky WH. Type 2 diabetes in the real world: the elusive nature of glycemic control. Diabetes Care. 2017;40(11):1425-1432. https://doi.org/10.2337/dc16-1974.

Related Content

Cardiometabolic Risk
Cardiometabolic Risk
Andrea Richardson on Environmental Interventions to Reduce Obesity
12/05/2018
Andrea Richardson, from RAND Corporation, discusses her research on obesity and environmental health. Which environmental interventions are the most successful?
12/05/2018
Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension
I’m Aware That I’m Rare: Eric Austin, part 1
12/07/2017
Eric Austin, MD, MSCI, from Vanderbilt University Medical Center, speaks about screening for pulmonary hypertension among high-risk patients who may not know they have it.
12/07/2017
Bacterial Infections
Bacterial Infections
Ephraim L. Tsalik, MD, MHS, PhD, on ID Host Response Biomarkers
11/19/2019
He discusses the biomarkers in the pipeline for diagnosing infectious diseases, including tuberculosis and sepsis, and details which ones are most likely to make it to clinical practice.
11/19/2019
Bacterial Infections
Bacterial Infections
Joseph Solomkin, MD, on the Results From the IGNITE4 Trial
10/18/2016
He answers our questions about the IGNITE4 trial, which evaluated eravacycline vs meropenem for the treatment of intra-abdominal infections among acutely hospitalized patients.
10/18/2016
Epilepsy
Epilepsy
Gregory Krauss, MD, on Adjunctive Cenobamate for Uncontrolled Focal Seizures
02/21/2020
He discusses his research on cenobamate as adjunctive therapy for adults with uncontrolled focal seizures, how the results of this research aided in cenobamate's approval by the Food and Drug...
02/21/2020